​

Funding Round

Venture Round - Crescendo Biologics

Venture Round - Crescendo Biologics

Investment Firm

Overview

Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.

Announced Date

Jul 24, 2023

Funding Type

Series Unknown

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorTakeda
Participant InvestorSofinnova Partners
Participant InvestorAndera Partners
Participant InvestorKreos Capital
Participant InvestorIP Group

Round Details and Background

Crescendo Biologics raised $32000000 on 2023-07-24 in Venture Round

Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 16, 2014
Venture Round - Crescendo Biologics
1-undefined
Apr 03, 2014
Series A - Crescendo Biologics
4-3.3M
Dec 17, 2013
Series A - Crescendo Biologics
3-28.5M
Jan 20, 2010
Series A - Crescendo Biologics
4-7.3M

Recent Activity

There is no recent news or activity for this profile.